Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review
Authors' conclusion
We report evidence that supports the use of this technology in people with T2D not using insulin.
Study context
- Population
- People with T2D not on insulin10 RCTs · 15 nonrandomized studies
- Comparison
- Continuous glucose monitoring (CGM) use in noninsulin-treated T2D
Primary result
As reported in the abstract
- Evidence supports the use of CGM in people with T2D not using insulin
Original publication
Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review. Diabetes Technol Ther. Published 23 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →